
This ETF's primary goal is to meticulously mirror the overall return of a specific benchmark index. It endeavors to replicate this performance as precisely as possible, excluding any operating costs or management fees. The index it tracks is designed to gauge the financial progress of smaller American companies, selecting and weighting them according to their core fundamental attributes like size and economic importance.
Is FNDA's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.

Looking for broad exposure to the Small Cap Value segment of the US equity market? You should consider the Schwab Fundamental U.S. Small Company ETF (FNDA), a passively managed exchange traded fund launched on August 13, 2013.


I downgrade Schwab Fundamental U.S. Small Company ETF to 'hold' due to declining EPS growth and price momentum. FNDA maintains quality advantages, especially by underweighting unprofitable biotech, but its growth-at-a-reasonable-price metrics no longer stand out. The ETF's next-year EPS growth estimate fell from 17.40% to 14.99% since July. However, sales growth is projected at just 7.62%, and I couldn't reconcile the difference.

Schwab Fundamental U.S. Small Company ETF (NYSEARCA:FNDA - Get Free Report) was the recipient of a large growth in short interest in the month of September. As of September 30th, there was short interest totaling 394,939 shares, a growth of 453.4% from the September 15th total of 71,365 shares. Currently, 0.2% of the shares of

The Schwab Fundamental U.S. Small Company ETF (FNDA) was launched on 08/13/2013, and is a smart beta exchange traded fund designed to offer broad exposure to the Style Box - Small Cap Value category of the market.